Skip to main content

Melanoma expert Ashani T. Weeraratna, PhD, of Johns Hopkins Bloomberg School of Public Health, explains how bemotrizinol—the first new sunscreen ingredient to be approved by the FDA in over 25 years—compares with currently used ingredients. Weeraratna breaks down how bemotrizinol works, its safety profile, its effectiveness, and more.

The post What to Know About the New FDA-approved Sunscreen Ingredient Bemotrizinol appeared first on American Association for Cancer Research (AACR).

Source: Oncology

Read More